Minted: - / 5000

4817 Omigapil
3b99caf1e6f9754bfef9a594e895170f40029299630ae04eab382e4b62b3de34

Properties

Background

Blue
Bottle

Blue
Cap

Purple
Syringe

Red
Bubbles
Yes
Drops
No
Label
-

Chemistry

Formula
C19H17NO
Carbon
19
Polarity
Neutral

Omigapil (TCH346 or CGP3466) is a drug that was developed by Novartis and tested in clinical trials for its ability to help treat Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). The development for PD and ALS have been terminated due to lack of benefit, but Santhera Pharmaceuticals bought the compound for development for the treatment of congenital muscular dystrophy (CMD).

From Wikipedia, the free encyclopedia. License: CC BY-SA.